Onkos Surgical to Distribute OsteoCrete Bone Void Filler
Onkos Surgical will market Bone Solutions' OsteoCrete® magnesium-based bone void filler under the GenVie brand through a private label agreement. Aug 28, 2019
Omar Ishrak to Retire as CEO of Medtronic
Medtronic Chief Executive Officer Omar Ishrak announced his intention to retire in the beginning of 2Q20. Geoff Martha, currently Executive Vice President of MDT's Restorative Therapies Group, will assume the newly-created role of Medtronic President in 4Q19 and succeed Ishrak as CEO next year. Aug 28, 2019
Ozop Surgical Enters into License Agreement with Spinal Resources
Ozop Surgical entered into an exclusive license agreement to sell various products from Spinal Resources. Aug 27, 2019
Fuse Medical Launches Sterizo Total Knee
Fuse Medical introduced the Sterizo Total Knee, with multiple stabilization options including Cruciate Retained, Ultra Congruent Anterior Stabilized and Posterior Stabilized. Aug 26, 2019
DiscGenics Receives FDA Fast Track Designation for Cell Therapy
DiscGenics was granted Fast Track designation from FDA for its investigational cell therapy, IDCT, under evaluation in clinical trials in the U.S. and Japan to treat pain and disability from degenerative disc disease. Aug 26, 2019
aap Implantate Gains FDA Clearance for LOQTEQ VA Calcaneus Plates
aap Implantate received FDA 510(k) clearance to market LOQTEQ® variable angle calcaneus plates 3.5 to treat heel fractures. Aug 21, 2019
OrthoPediatrics Gains FDA Clearance for PediFoot Deformity Correction
OrthoPediatrics received FDA 510(k) clearance to market the PediFoot Deformity Correction system. Product launch is slated for 3Q19. Aug 21, 2019
Paragon 28 Launches Silverback Ankle Fusion Plates
Paragon 28 launched the Silverback Ankle Fusion Plating System for tibiotalar and tibiotalocalcaneal ankle arthrodesis. Aug 21, 2019
Intellirod Spine Launching iLink Wearable Sensor
Intellirod Spine introduced iLink®, a Bluetooth sensor that provides data on spine brace compliance. Aug 21, 2019
Cutting Edge Spine Gains FDA Clearance of EVOL-SI Joint Fusion
Cutting Edge Spine received FDA 510(k) clearance to market EVOL-SI, a sacroiliac joint fusion system. Aug 20, 2019
